{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:22:02Z","timestamp":1790677322833,"version":"4.1.0"},"reference-count":22,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.3892\/mco.2014.410","type":"journal-article","created":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T19:19:05Z","timestamp":1409858345000},"page":"217-221","source":"Crossref","is-referenced-by-count":301,"title":["Specific organ metastases and survival in metastatic non-small-cell lung cancer"],"prefix":"10.3892","volume":"3","author":[{"given":"TOMOHIRO","family":"TAMURA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOICHI","family":"KURISHIMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KENSUKE","family":"NAKAZAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KATSUNORI","family":"KAGOHASHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROICHI","family":"ISHIKAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROAKI","family":"SATOH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NOBUYUKI","family":"HIZAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,9,4]]},"reference":[{"key":"key20180107145346_b1-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jjco\/hyu003","article-title":"Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project","volume":"44","author":"Matsuda","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"key20180107145346_b2-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.lungcan.2007.03.012","article-title":"National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care","volume":"57","author":"Little","year":"2007","journal-title":"Lung Cancer"},{"key":"key20180107145346_b3-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1200\/JCO.1986.4.5.702","article-title":"Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study","volume":"4","author":"Finkelstein","year":"1986","journal-title":"J Clin Oncol"},{"key":"key20180107145346_b4-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1988.6.9.1474","article-title":"Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis","volume":"6","author":"Sorensen","year":"1988","journal-title":"J Clin Oncol"},{"key":"key20180107145346_b5-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1200\/JCO.2005.04.177","article-title":"Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on Eastern Cooperative Oncology Group data","volume":"23","author":"Hoang","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107145346_b6-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cllc.2013.05.002","article-title":"Determinants of survival in advanced non-small-cell lung cancer in the era of targeted therapies","volume":"14","author":"Bauml","year":"2013","journal-title":"Clin Lung Cancer"},{"key":"key20180107145346_b7-mco-03-01-0217","first-page":"9","volume-title":"World Health Organization Classification of Tumours","author":"Travis","year":"2004"},{"key":"key20180107145346_b8-mco-03-01-0217","first-page":"136","volume-title":"TNM Classification of Malignant Tumours","author":"Sobin","year":"2009","edition":"7th"},{"key":"key20180107145346_b9-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J Roy Statist Soc Ser B Metho"},{"key":"key20180107145346_b10-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF00390866","article-title":"Prognostic factors in non-small cell lung cancer: multiregression analysis in the National Cancer Center Hospital (Japan)","volume":"113","author":"Sakurai","year":"1987","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107145346_b11-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-5002(96)00609-5","article-title":"Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC)","volume":"16","author":"Borges","year":"1996","journal-title":"Lung Cancer"},{"key":"key20180107145346_b12-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3816\/CLC.2008.n.018","article-title":"Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective","volume":"9","author":"Paralkar","year":"2008","journal-title":"Clin Lung Cancer"},{"key":"key20180107145346_b13-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1054\/bjoc.2000.1706","article-title":"Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors","volume":"84","author":"Jacot","year":"2001","journal-title":"Br J Cancer"},{"key":"key20180107145346_b14-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2008.04.013","article-title":"Non-small cell lung cancer and silent brain metastasis. Survival and prognostic factors","volume":"63","author":"Sanchez de Cos","year":"2009","journal-title":"Lung Cancer"},{"key":"key20180107145346_b15-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/cncr.22991","article-title":"Pathologic fractures correlate with reduced survival in patients with malignant bone disease","volume":"110","author":"Saad","year":"2007","journal-title":"Cancer"},{"key":"key20180107145346_b16-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/ijc.24470","article-title":"The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis","volume":"125","author":"Zarogoulidis","year":"2009","journal-title":"Int J Cancer"},{"key":"key20180107145346_b17-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/MO:20:1:25","article-title":"Liver metastasis at the time of initial diagnosis of lung cancer","volume":"20","author":"Kagohashi","year":"2003","journal-title":"Med Oncol"},{"key":"key20180107145346_b18-mco-03-01-0217","first-page":"70","article-title":"Prognostic value of response to chemotherapy using ultrasound in lung cancer with metastatic liver involvement","volume":"57","author":"Gorg","year":"1990","journal-title":"Bildgebung"},{"key":"key20180107145346_b19-mco-03-01-0217","first-page":"737","article-title":"Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience","volume":"15","author":"Yamamoto","year":"1999","journal-title":"Int J Oncol"},{"key":"key20180107145346_b20-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ejcts.2008.05.016","article-title":"Postrecurrence survival in patients with stage I non-small cell lung cancer","volume":"34","author":"Nakagawa","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"key20180107145346_b21-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"137S","DOI":"10.1378\/chest.123.1_suppl.137S","article-title":"Noninvasive staging of non-small cell lung cancer: a review of the current evidence","volume":"123","author":"Toloza","year":"2003","journal-title":"Chest"},{"key":"key20180107145346_b22-mco-03-01-0217","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/SMJ.0b013e3181a56042","article-title":"Adrenal insufficiency as a presenting manifestation of nonsmall cell lung cancer","volume":"102","author":"Mohammad","year":"2009","journal-title":"South Med J"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2014.410\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T06:44:18Z","timestamp":1717310658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2014.410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,4]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,9,4]]},"published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.3892\/mco.2014.410"],"URL":"https:\/\/doi.org\/10.3892\/mco.2014.410","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,4]]}}}